MedTrace Logo

Catecholamines Level in Vitiligo Patients Before and After Excimer Light

NCT04803461 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2021-03-17

No results posted yet for this study

Summary

Vitiligo is an acquired cutaneous disorder of pigmentation, with a 1-2% incidence worldwide, without predilection for sex or race. People affected by vitiligo have a vast reduction of quality of life, caused by the color contrast between healthy pigmented skin and the depigmented vitiligo patches due to death of melanocytes, which may cause psychological problems to the patient.

Conditions

  • Vitiligo, Generalized

Interventions

DIAGNOSTIC_TEST

serum and urinary catecholamines

estimation of level of serum and urinary catecholamines before and after excimer light treatment for patient with non segmental vitiligo.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2022-04-01
Completion
2022-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04803461 on ClinicalTrials.gov